Self-management interventions to reduce healthcare use and improve quality of life among patients with asthma: systematic review and network meta-analysis.


Journal

BMJ (Clinical research ed.)
ISSN: 1756-1833
Titre abrégé: BMJ
Pays: England
ID NLM: 8900488

Informations de publication

Date de publication:
18 08 2020
Historique:
entrez: 21 8 2020
pubmed: 21 8 2020
medline: 1 9 2020
Statut: epublish

Résumé

To compare the different self-management models (multidisciplinary case management, regularly supported self-management, and minimally supported self-management) and self-monitoring models against usual care and education to determine which are most effective at reducing healthcare use and improving quality of life in asthma. Systematic review and network meta-analysis. Medline, the Cochrane Library, CINAHL, EconLit, Embase, Health Economics Evaluations Database, NHS Economic Evaluation Database, PsycINFO, and ClinicalTrials.gov from January 2000 to April 2019. Randomised controlled trials involving the different self-management models for asthma were included. The primary outcomes were healthcare use (hospital admission or emergency visit) and quality of life. Summary standardised mean differences (SMDs) and 95% credible intervals were estimated using bayesian network meta-analysis with random effects. Heterogeneity and publication bias were assessed. From 1178 citations, 105 trials comprising 27 767 participants were included. In terms of healthcare use, both multidisciplinary case management (SMD -0.18, 95% credible interval -0.32 to -0.05) and regularly supported self-management (-0.30, -0.46 to -0.15) were significantly better than usual care. For quality of life, only regularly supported self-management (SMD 0.54, 0.11 to 0.96) showed a statistically significant benefit compared with usual care. For trials including adolescents/children (age 5-18 years), only regularly supported self-management showed statistically significant benefits (healthcare use: SMD -0.21, -0.40 to -0.03; quality of life: 0.23, 0.03 to 0.48). Multidisciplinary case management (SMD -0.32, -0.50 to -0.16) and regularly supported self-management (-0.32, -0.53 to -0.11) were most effective at reducing healthcare use in patients with symptoms of severe asthma at baseline. This network meta-analysis indicates that regularly supported self-management reduces the use of healthcare resources and improves quality of life across all levels of asthma severity. Future healthcare investments should provide support that offer reviews totalling at least two hours to establish self-management skills, reserving multidisciplinary case management for patients with complex disease. PROSPERO number CRD42019121350.

Identifiants

pubmed: 32816816
doi: 10.1136/bmj.m2521
pmc: PMC7431958
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

m2521

Subventions

Organisme : Department of Health
ID : RP-PG-1016-20008
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: funding support from the Evidence Synthesis Working Group (project 390), NIHR School for Primary Care Research, and NIHR Greater Manchester Patient Safety Translational Research Centre for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Références

Allergy. 2004 May;59(5):469-78
pubmed: 15080825
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
BMC Med Res Methodol. 2013 Mar 09;13:35
pubmed: 23496991
J Pediatr Psychol. 2009 Oct;34(9):917-28
pubmed: 19223279
BMJ. 2014 Mar 11;348:g1741
pubmed: 24618053
BMC Med. 2015 Jun 01;13:127
pubmed: 26032941
Prim Care Respir J. 2003 Dec;12(4):110-114
pubmed: 31700369
J Am Med Inform Assoc. 2017 May 01;24(3):619-632
pubmed: 27694279
BMJ. 1990 Sep 29;301(6753):651-3
pubmed: 1977482
Thorax. 2007 Dec;62(12):1039-42
pubmed: 17573445
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
N Engl J Med. 2006 Nov 23;355(21):2226-35
pubmed: 17124020
J Clin Epidemiol. 2017 Mar;83:48-56
pubmed: 28126599
Stat Med. 2017 Nov 30;36(27):4266-4280
pubmed: 28815652
Br J Gen Pract. 2020 Apr 30;70(694):e303-e311
pubmed: 32205333
BMC Med. 2015 Mar 23;13:58
pubmed: 25857569
Cochrane Database Syst Rev. 2017 Apr 10;4:CD011859
pubmed: 28394084
Breathe (Sheff). 2015 Jun;11(2):98-109
pubmed: 26306110
BMC Med. 2017 Mar 17;15(1):64
pubmed: 28302126
BMJ Evid Based Med. 2018 Apr;23(2):56-59
pubmed: 29595131
Cochrane Database Syst Rev. 2019 Jan 28;1:CD011651
pubmed: 30687940
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S88-123
pubmed: 22386511
Ann Intern Med. 2015 Jun 2;162(11):777-84
pubmed: 26030634
J Clin Epidemiol. 2011 Feb;64(2):163-71
pubmed: 20688472
London J Prim Care (Abingdon). 2012;5(1):35-47
pubmed: 25949665
J Adolesc Health. 2013 Apr;52(4):419-26
pubmed: 23299008
NPJ Prim Care Respir Med. 2017 Oct 9;27(1):57
pubmed: 28993623
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Cochrane Database Syst Rev. 2003;(1):CD001117
pubmed: 12535399
Stat Med. 2010 Mar 30;29(7-8):932-44
pubmed: 20213715
NPJ Prim Care Respir Med. 2017 Jul 18;27(1):45
pubmed: 28720751
Res Synth Methods. 2012 Jun;3(2):98-110
pubmed: 26062084
NPJ Prim Care Respir Med. 2018 Feb 15;28(1):5
pubmed: 29449558
Evid Based Ment Health. 2016 Feb;19(1):16-21
pubmed: 26792834
BMC Fam Pract. 2015 Oct 21;16:145
pubmed: 26487557
Thorax. 2008 May;63 Suppl 4:iv1-121
pubmed: 18463203
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006344
pubmed: 17943904
BMC Public Health. 2012 Mar 19;12:204
pubmed: 22429515
NPJ Prim Care Respir Med. 2018 Nov 6;28(1):42
pubmed: 30401831
J Health Serv Res Policy. 2016 Apr;21(2):73-82
pubmed: 26377727
PLoS One. 2013 Oct 03;8(10):e76654
pubmed: 24098547
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
Eur Respir J. 2011 Feb;37(2):310-7
pubmed: 20562122

Auteurs

Alexander Hodkinson (A)

National Institute for Health Research School for Primary Care Research, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK alexander.hodkinson@manchester.ac.uk.

Peter Bower (P)

National Institute for Health Research School for Primary Care Research, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK.

Christos Grigoroglou (C)

National Institute for Health Research School for Primary Care Research, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK.

Salwa S Zghebi (SS)

National Institute for Health Research School for Primary Care Research, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK.

Hilary Pinnock (H)

Asthma UK Centre for Applied Research, Usher Institute, University of Edinburgh, Edinburgh, UK.

Evangelos Kontopantelis (E)

National Institute for Health Research School for Primary Care Research, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK.
Faculty of Biology, Medicine & Health, Division of Informatics, Imaging & Data Sciences, University of Manchester, Manchester, UK.

Maria Panagioti (M)

National Institute for Health Research School for Primary Care Research, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK.
National Institute for Health Research Greater Manchester Patient Safety Translational Research Centre, Division of Population Health, Health Services Research & Primary Care, University of Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH